Manufacturers Life Insurance Company, The Rhythm Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 48,703 shares of RYTM stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,703
Previous 49,291
1.19%
Holding current value
$3.02 Million
Previous $2.02 Million
26.1%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding RYTM
# of Institutions
192Shares Held
67.3MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$448 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$418 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$397 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$377 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$241 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.46B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...